CR MEDICAL (01515) announced its annual results for the period ending December 31, 2025. The group recorded revenue of RMB 9.176 billion, a decrease of 6.9% compared to the previous year. Profit attributable to the company's owners was RMB 496 million, down 12.36% year-on-year. Earnings per share stood at RMB 0.39, with a proposed final dividend of RMB 0.084 per share.

During the reporting period, the hospital business segment reported an operating revenue of RMB 8.675 billion, a decline of 5.5% from the prior year. Outpatient and emergency visits increased by 3.4%, while inpatient admissions decreased by 2.7%. Due to medical insurance cost control measures, average revenue per outpatient and emergency visit dropped by 6.6%, and average revenue per inpatient admission fell by 4.9%.

The company worked to mitigate the impact of declining average revenue on hospital business profits through quality improvement and operational efficiency. The hospital business segment's gross profit was RMB 1.367 billion, down 17.3% year-on-year, with a gross margin of 15.8%. Segment performance for the hospital business was approximately RMB 500 million, a decrease of 34.7% compared to the previous year, primarily due to the reduction in average fees.